Mixed
Sarcopenia, defined as depleted muscle mass, is a prevalent condition in chronically ill non-elderly patients (cancer, liver failure, ICU) and is strongly associated with adverse clinical outcomes including higher mortality, prolonged hospitalization, and increased infectious complications.
If you are chronically ill (e.g., cancer, liver disease) or in the ICU, ask your care team if your muscle mass has been assessed, particularly if you have had a CT scan. Standard weight checks may miss muscle loss (sarcopenia), which is linked to higher risks of complications and death. Identifying this early allows for targeted interventions to preserve muscle.
Recent studies suggest that prevalence of CT-defined sarcopenia is high among chronically ill patients, ranging from 15%–50% in patients with cancer, 30%–45% with liver failure, and 60%–70% for critically ill patients in the intensive care unit. Depleted muscle mass is associated with infectious complications, prolonged duration of mechanical ventilation, longer hospitalization, greater need for rehabilitation care after hospital discharge, and higher mortality.
Why this rating
Based on a review of multiple observational studies using CT-defined sarcopenia, which is a precise biomarker, though not an RCT of intervention.
Source
Prevalence of Sarcopenia and Associated Outcomes in the Clinical Setting
Sarah J. Peterson et al. · Nutrition in Clinical Practice · 2015
DOI 10.1177/0884533615622537
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →